Long-Acting Reversible Contraception, Condom Use, and Sexually Transmitted Infections: A Systematic Review and Meta-analysis

Steiner, Riley J.; Pampati, Sanjana; Kortsmit, Katherine; Liddon, Nicole; Swartzendruber, Andrea; Pazol, Karen

doi:10.1016/j.amepre.2021.04.032

Cited by 16 publications

(17 citation statements)

References 72 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Reassuringly, the rates of STIs were similar among free-of-charge LARC initiators and SARC users, and among women initiating different LARC methods. Previous studies suggest that LARC users may be less likely to use condoms as dual protection compared to women using less effective contraceptive options such as SARCs making them to be at higher risk to contract sexually transmitted infections [ 23 – 27 ]. However, results in previous studies comparing the occurrence of STIs is between LARC users and SARC users are conflicting [ 23 , 27 , 28 ].…”

Section: Discussionmentioning

confidence: 99%

“…Previous studies suggest that LARC users may be less likely to use condoms as dual protection compared to women using less effective contraceptive options such as SARCs making them to be at higher risk to contract sexually transmitted infections [ 23 – 27 ]. However, results in previous studies comparing the occurrence of STIs is between LARC users and SARC users are conflicting [ 23 , 27 , 28 ]. The CHOICE study found increased odds of STIs among LARC initiators, whereas a study on adolescents in New York reported a similar rate of chlamydia infections among LARC users and non-users [ 27 , 28 ].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

et al. 2022

View full text Add to dashboard Cite

Background Long-acting reversible contraceptives (LARCs) have superior contraceptive efficacy compared to short-acting reversible contraceptives (SARCs) and choosing LARCs over SARC methods reduces the need for abortion care. However, little is known how initiating these methods associates with the subsequent overall need of reproductive health services including family planning services, and visits for gynecological reasons in primary and specialized care. Methods We followed altogether 5839 non-sterilized women aged 15–44 years initiating free-of-charge LARC methods (n = 1689), initiating or switching SARC methods (n = 1524), or continuing with the same SARC method (n = 2626) at primary care family planning clinics in the City of Vantaa, Finland, 2013–2014 for 2 years using Finnish national health registers. We assessed the use of reproductive health services, namely attending public primary or specialized health care for gynecological reasons or attending the family planning clinics by applying unadjusted and adjusted negative binomial regression models on visit counts. Results A total of 11,290 visits accumulated during the two-year follow-up: 7260 (64.3%) at family planning clinics, 3385 (30.0%) for gynecological reasons in primary, and 645 (5.7%) in specialized health care. Altogether 3804 (52.4%) visits at the family planning clinics were for routine checkup, and 3456 (47.6%) for other reasons. Women initiating LARC methods used reproductive health services for reasons other than routine checkups similarly as women initiating or switching SARC methods (adjusted incidence rate ratio 0.93, 95% CI 0.82–1.05), while women continuing with SARC methods used the services less frequently (0.65, 0.59–0.72). Women initiating free-of-charge LARC and those continuing with the same SARC method used services less for abortion care than women initiating or switching SARC (adjusted incidence rate ratios 0.05, 95% CI 0.03–0.08 and 0.16, 95% CI 0.11–0.24, respectively). Conclusions While women initiating LARC methods have lower need for abortion care compared to women initiating SARC methods, women initiating both LARC and SARC methods have similar overall need for reproductive health services. In contrast, women continuing with their SARC method need reproductive health services less than women initiating LARC or a new SARC method. These service needs should be acknowledged when planning and organizing family planning services, and when promoting long-acting reversible contraception.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Although contraceptive transdermal patches were introduced in 2002, the transdermal patches failed to gain popularity by women due to the long wearing time (i.e., 1 week) and low drug permeation efficiency [60,61]. Unlike transdermal patches, MN patches have attracted increasing attention for long-acting contraception owing to the fact that MN patches can directly penetrate the skin and deliver the payload to the skin with significantly improved transdermal delivery efficiency [62].…”

Section: Acceptability Of Mn Patches For Long-acting Contraceptionmentioning

confidence: 99%

Advances in microneedle patches for long-acting contraception

Jiang

Zeng

Zhang

et al. 2023

Acta Materia Medica

View full text Add to dashboard Cite

Despite the advances in contraceptives, there is still a high rate of unintended pregnancies worldwide, due in large part to the lack of effective, convenient, and safe birth control methods. Compared with short-acting contraceptives, approaches that offer long-term pregnancy protection have attracted greater interest because of the reduced dosing frequency and improved patient compliance. As a novel transdermal drug delivery system, the microneedle (MN) patch has been widely used for a variety of biomedical applications, including long-acting contraception, due to unique properties, such as painless self-administration and elimination of biohazardous waste. In this review we provide a systemic review of MN patches that have been utilized for long-term contraception, including dissolvable MN patches, polymeric biodegradable MN patches, and silk fibroin-based biodegradable MN patches. The acceptability and biosafety of these contraceptive MN patches are also discussed. Finally, we give our perspectives on the future clinical translation of MN patches for long-acting contraception.

show abstract

“…A recent national survey identified that only 10.3% of individuals using contraception used both a contraceptive method and condoms 2 . Individuals using a LARC method may be 40% to 60% less likely to engage in dual use than individuals using the pill, patch, ring, or injectable contraception 3 . However, individuals who use LARC have historically been older and more likely to be in a monogamous relationship than those who do not use LARC 4 which means the groups vary in terms of exposure and risk of STIs at baseline.…”

Section: Long‐acting Reversible Contraception Users May Be Less Likel...mentioning

confidence: 99%

Research and Professional Literature to Inform Practice, March/April 2023

Alspaugh

2023

J Midwife Womens Health

View full text Add to dashboard Cite

Long-Acting Reversible Contraception, Condom Use, and Sexually Transmitted Infections: A Systematic Review and Meta-analysis

Cited by 16 publications

References 72 publications

Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

Use of reproductive health services among women using long- or short-acting contraceptive methods – a register-based cohort study from Finland

Advances in microneedle patches for long-acting contraception

Research and Professional Literature to Inform Practice, March/April 2023

Contact Info

Product

Resources

About